New methods to analyze complex microbiome data
Novel Statistical Methods for Analyzing Complex Microbiome Data
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-10813127
This study is all about figuring out how tiny germs in our bodies can impact our health, and it's designed for researchers who want to better understand these germs and their effects by using new, easy-to-use tools.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10813127 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how different microbes affect human health and diseases by developing advanced statistical methods for analyzing microbiome data. It addresses the unique challenges posed by this data, such as its complexity and potential biases, which can lead to inaccurate results. The project aims to create robust methods that can handle various types of data and test different hypotheses related to microbiome health. Additionally, a user-friendly software program will be developed to help researchers apply these new methods effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, diabetes, or other conditions influenced by microbiome health.
Not a fit: Patients with conditions unrelated to microbiome health or those not diagnosed with the target conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate insights into the role of the microbiome in health and disease, potentially improving diagnosis and treatment options for conditions like Alzheimer's and diabetes.
How similar studies have performed: Previous research has shown promise in developing statistical methods for microbiome analysis, but this project aims to introduce novel approaches that have not been extensively tested.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SU, CHANG — EMORY UNIVERSITY
- Study coordinator: SU, CHANG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Cancers